Ludwig Cancer Research

Life-changing
science

At every step of the research process from the lab to the clinic, we are pursuing innovative ways to prevent and control cancer.

Reprogramming cancer cells to treat an aggressive type of leukemia

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Magazine

Hyperplexed image of a glioblastoma fibrotic core, caused by treatment of the primary tumor. Cells in green are recurrent tumor growth emanating from the core.

The December 2024 issue of Ludwig Link includes a rich lineup of research briefs, Q&As and a deep dive into a research initiative at Ludwig Lausanne.

Meet our scientists

Jenny Hogstrom, Quenton Rashawn Bubb and Jacqueline Douglass, Ludwig Cancer Research

Three Ludwig Center trainees took a few minutes out of their very busy schedules to tell us about their lives, scientific fascinations, avocational passions and views on a variety of issues.

Women in science

This special report on Women in Science celebrates the women leaders of Ludwig Cancer Research with profiles of eight outstanding scientists and their thoughts on gender-related issues and the advancement of women in biomedical research.